Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin

Journal of Sleep Research

Volumn 19, Issue 4, 2010, Pages 620-623

  Bassetti, Claudio L ^a   Baumann, Christian R ^a   Dauvilliers, Yves ^b   Croyal, Michael ^c   Robert, Philippe ^c   Schwartz, Jean Charles ^c  

^a Ospedale Civico Lugano   (Switzerland)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c Bioprojet Biotech ^*  (France)

Author keywords

CSF; EDS; Histamine; Hypersomnia; Hypocretin; Narcolpesy; Orexin

Indexed keywords

ACETYLSALICYLIC ACID; ALPRENOLOL; CENTRAL STIMULANT AGENT; GABAPENTIN; GLATIRAMER; HISTAMINE; IBUPROFEN; INTERFERON; LAMOTRIGINE; METFORMIN; MODAFINIL; OREXIN A; PARACETAMOL; VENLAFAXINE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; DAYTIME SOMNOLENCE; EPILEPSY; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SOMNOLENCE; FEMALE; HEADACHE; HUMAN; HYPERSOMNIA; LUMBAR PUNCTURE; MALE; MULTIPLE SCLEROSIS; NARCOLEPSY; POLYNEUROPATHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP DISORDER; WAKEFULNESS;

ADULT; AGED; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HISTAMINE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NARCOLEPSY; SLEEP APNEA SYNDROMES; WAKEFULNESS; YOUNG ADULT;

EID: 77958579815     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2010.00819.x     Document Type: Article

References (21)

1. Bassetti, C., Hersberger, M. and Baumann, C. CSF prostaglandin D synthase is reduced in excessive daytime sleepiness. J. Neurol., 2006, 253: 1030-1033.
2. Baumann, C. and Bassetti, C. L. Hypocretin and narcolepsy. Lancet Neurol., 2005, 10: 673-682.
3. Baumann, C. R., Dauvilliers, Y., Maly, F. E., Mignot, E. and Bassetti, C. L. Normal CSF-1 (orexin-A) levels in dementia with diffuse Lewy bodies. Eur. Neurol., 2004, 52: 73-76.
4. Baumann, C., Khatami, R., Werth, E. and Bassetti, C. L. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J. Neurol. Neurosurg. Psychiatry, 2006, 77: 402-404.
5. De Lecea, L., Kilduff, T. S., Peyron, C., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci., 1998, 95: 322-327.
6. Faucard, R. and Schwartz, J. C. Neuropharmacology of histamine in brain. In: D. R. Sibley, I. Hanin, M. Kuhar and P. Skolnick (Eds), Handbook of Contemporary Neuropharmacology, John Wiley & Sons, New York, vol. 1. 2007: 299-364.
7. Haas, H. and Panula, P. Role of histamine and the tuberomamillary nucleus in the nervous system. Nat. Rev. Neurosci., 2003, 4: 121-128.
8. Huang, Z. L., Qu, W. M., Li, W. D., et al. Arousal effect of orexin A depends on activation of the histamine system. Proc. Natl. Acad. Sci., 2003, 98: 9965-9970.
9. Kanbayashi, T., Kodama, H., Hondo, S., et al. CSF histamine and noradrenaline contents in narcolepsy and other sleep disorders [Abstract]. Sleep, 2004, 27: A236.
10. Lin, J. S., Dauvilliers, Y., Arnulf, I., Bastuji, H., et al. An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: studies in orexin -/- mice and patients. Neurobiol. Dis., 2008, 30: 74-83.
11. Mignot, E., Lammers, G. J., Ripley, B., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol., 2002, 59: 1553-1562.
12. Mochizuki, T., Yamatodani, A., Okakura, K., et al. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol. Behav., 2002, 51: 391-394.
13. Nishino, N., Ripley, B., Overeem, S., Lammers, G. J. and Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000, 355: 39-40.
14. Nishino, S., Fujiki, N., Ripley, B., et al. Decreased brain histamine content in hypocretin/orexin receptro-2 mutated narcoleptic dogs. Neurosci. Lett., 2002a, 313: 125-128.
15. Nishino, S., Sakurai, E., Nevsimalova, S., et al. CSF histamine content is decreased in hypocretin-deficient human narcolepsy [Abstract]. Sleep, 2002b, 25: A476.
16. Peyron, C., Tighe, D. K., Von Den Pool, A. N., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci., 1998, 18: 9996-10015.
17. Peyron, C., Faraco, J., Rogers, W., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med., 2000, 6: 991-997.
18. Sakurai, T., Amemiya, A., Ishii, M., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell, 1998, 92: 573-585.
19. Soya, A., Song, Y. H., Kodama, T., Honda, Y., Fujiki, N. and Nishino, S. CSF histamine levels in rats reflect the central histamine neurotransmission. Neurosci. Lett., 2008, 430: 224-229.
20. Thannickal, T. C., Moore, R. Y., Nienhuis, R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27: 469-474.
21. Urade, Y. and Hayashi, O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim. Biophys. Acta, 2000, 1482: 259-271.